Stage 2 Stocks in Medical Instruments & Supplies
17 US stocks in Medical Instruments & Supplies are in Stage 2, the advancing phase of Weinstein's stage analysis. Listed below: those priced at $5 or more and trading at least $1 million a day on average, ranked by setup score and updated after every close (last close Oct 23, 2026).
| Stock | Close | 1D | Setup | Weeks in stage |
|---|---|---|---|---|
| KMTS Kestra Medical Technologies, Ltd. | $28.76 | +1.55% | 7.9 | 10 |
| AVTR Avantor, Inc. | $17.29 | +0.82% | 7.4 | 12 |
| WST West Pharmaceutical Services, Inc. | $392.15 | -0.48% | 7.0 | 24 |
| MMSI Merit Medical Systems, Inc. | $93.30 | -0.68% | 6.6 | 10 |
| AZTA Azenta, Inc. | $36.50 | +1.36% | 6.6 | 9 |
| RMD ResMed Inc. | $252.86 | -0.08% | 6.5 | 3 |
| BDX Becton, Dickinson and Company | $198.91 | -0.75% | 6.1 | 11 |
| ATRC AtriCure, Inc. | $58.97 | -0.56% | 6.0 | 11 |
| PLSE Pulse Biosciences, Inc | $53.02 | +0.65% | 5.8 | 35 |
| UTMD Utah Medical Products, Inc. | $74.23 | -1.11% | 5.6 | 38 |
| SMTI Sanara MedTech Inc. | $32.80 | -0.24% | 5.3 | 14 |
| RGEN Repligen Corporation | $176.93 | -1.00% | 4.9 | 11 |
| SOLV Solventum Corporation | $85.41 | -2.33% | 4.8 | 17 |
| PDEX Pro-Dex, Inc. | $62.22 | -0.26% | 4.4 | 36 |
| BLCO Bausch + Lomb Corporation | $17.47 | +0.23% | 3.9 | 9 |
Medical Instruments & Supplies: quick answers
Which stocks in Medical Instruments & Supplies are in an uptrend?
As of Oct 23, 2026, 17 US stocks in Medical Instruments & Supplies are in Stage 2, the uptrend phase. The largest by market value are Becton, Dickinson, ResMed, West Pharmaceutical Services, Solventum and Avantor.
How many stocks in Medical Instruments & Supplies are in Stage 2?
17 of the 51 stocks we track in Medical Instruments & Supplies (33.3%) are in Stage 2. 4 are basing in Stage 1, 9 are topping in Stage 3 and 19 are in a Stage 4 downtrend. That share has fallen 12.7 points over the last 20 sessions.
Which stocks in Medical Instruments & Supplies entered Stage 2 recently?
1 stock entered Stage 2 in the last four weeks: ResMed (week 3).
Daily screens
Every one recalculated after the close, with the exact criteria published on the page.
Stage 2 in other sectors & industries
US stocks in a confirmed uptrend (Stage 2, Weinstein’s advancing phase), grouped by sector and industry and ranked by setup score.